Top

Category: Vaccines


Industry, Vaccines

FDA Approves Vaccine for Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents

October 30, 2023

Via: Biopharm International

On Oct. 20, 2023 Pfizer announced that PENBRAYA, its vaccine for meningococcal groups A, B, C, W, and Y, has been approved by FDA. According to Pfizer, PENBRAYA is the first and only vaccine to protect against the five most […]


Industry, Vaccines

A New Era of Vaccines Leaves Old Questions About Prices Unanswered

October 27, 2023

Via: Kaiser Health News

The world is entering a new era of vaccines. Following the success of covid-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus’s structure, putting a host of new vaccines on the horizon. The most […]


Industry, Vaccines

University of Oxford launches new trial to enhance flu and COVID-19 vaccines

October 27, 2023

Via: PMLiVE

Funded by the Medical Research Council part of UK Research and Innovation, the LEGACY03 trial will contribute to future vaccine designs to enhance protection for those most vulnerable to diseases. As the immune systems changes with age, the body’s response […]


Industry, Vaccines

FDA Finalizes Guidance on Development of COVID-19 Vaccines

October 24, 2023

Via: Biopharm International

FDA announced on Oct. 19, 2023 that it had issued the final guidance, Development and Licensure of Vaccines to Prevent COVID-19, to help sponsors with the clinical development and licensure of COVID-19 vaccines. The document does not address every consideration […]


Industry, Vaccines

Pandemic Didn’t Lower Parents’ Trust in Childhood Vaccines

October 23, 2023

Via: Drugs.com

Lots of vaccine disinformation spread during the pandemic, and doctors worried that may have given some parents pause about not only the risks of the COVID shot, but of childhood vaccines as well. Now, new research puts that worry to […]


Industry, Vaccines

Pfizer wins FDA approval of new meningococcal vaccine

October 23, 2023

Via: Biopharma Dive

Two types of meningococcal vaccines are already available in the U.S. Some protect against serogroups A,C, W and Y, while other shots, like Trumenba, protect against serogroup B. The Centers for Disease Control and Prevention recommends children aged 11 or […]


Industry, Vaccines

‘Project NextGen’ picks new mRNA, intranasal COVID vaccines for funding

October 13, 2023

Via: Biopharma Dive

The U.S. government announced Friday the selection of three “next generation” COVID-19 vaccine candidates, awarding millions of dollars to support mid-stage clinical trials of the shots as part of the Project NextGen initiative. Launched in May by the Department of […]


Industry, Vaccines

2023 Nobel Prize in Medicine Awarded for Development of mRNA Vaccines Against COVID-19

October 4, 2023

Via: Biopharm International

On Oct. 2, 2023, The Nobel Prize in Physiology or Medicine was awarded jointly to Katalin Karikó and Drew Weissman for their work on nucleoside base modifications that allowed the development of effective messenger RNA (mRNA) vaccines against COVID-19. The […]


Industry, Vaccines

FDA Authorizes Updated Novavax COVID-19 Vaccine

October 4, 2023

Via: Drugs.com

Federal regulators on Tuesday gave the go-ahead to an updated Novavax COVID vaccine, giving Americans a more traditional alternative to two recently revamped mRNA vaccines. Adolescents and adults who have previously received a COVID vaccine, but who haven’t gotten the […]


Industry, Vaccines

Inside Bavarian Nordic’s late-stage stumbles — and drive to become a vaccine giant

September 27, 2023

Via: Biopharma Dive

Riding high from sales of an mpox vaccine, Bavarian Nordic began 2023 with one major goal in mind: becoming one of the largest pure-play vaccine manufacturers in the world. While the Danish biotechnology company has worked on vaccines since its […]


Industry, Vaccines

Many Americans Frustrated in Search for Low-Cost COVID Boosters

September 22, 2023

Via: Drugs.com

Americans seeking out the new COVID boosters are finding themselves held back by insurance entanglements and supply delays. Some insurers have balked at covering the vaccines, with people arriving at shot appointments only to be told that they’ll have to […]


Industry, Vaccines

FDA approves Pfizer/BioNTech and Moderna’s adapted COVID-19 vaccines

September 18, 2023

Via: Pharma Times

The updated vaccines more closely target current circulating variants The US Food and Drug Administration (FDA) has granted approval for Pfizer/BioNTech and Moderna’s updated COVID-19 vaccines, to tackle currently circulating variants. As previously recommended by the FDA, both vaccines have […]


Industry, Vaccines

NHS bookings for COVID-19 vaccinations open as winter programme starts early

September 18, 2023

Via: PMLiVE

Millions of eligible people in England can now book their vaccine via the NHS website, the NHS app, or by calling 119 for free if they do not have access online. From this week, people aged 65 and over, pregnant […]


Industry, Vaccines

US CDC recommends updated COVID-19 vaccines for autumn/winter season

September 14, 2023

Via: PMLiVE

The recommendation comes after the US Food and Drug Administration (FDA) approved updated COVID-19 vaccines from Pfizer/BioNTech and Moderna, which will be available later this week. Novavax’s protein-based updated COVID-19 vaccine is currently still under FDA review and showed promise […]


Industry, Vaccines

In Good News for U.S., Flu Vaccine Working Well in South America

September 11, 2023

Via: Drugs.com

In a finding that should ease the minds of Americans ahead of another flu season, this year’s vaccines have already cut the risk of hospitalization in half during the South American winter, health officials report. Even better, the flu virus […]


Industry, Vaccines

FDA Approval of New COVID Boosters Could Come by Friday

September 7, 2023

Via: Drugs.com

New COVID-19 booster shots could soon pass the needed hurdles for vaccinations to begin next week. Sources familiar with U.S. Food and Drug Administration plans say boosters could be approved as soon as Friday, NBC News reported. The U.S. Centers […]


Industry, Vaccines

GSK invests over $270m in vaccine manufacturing ahead of RSV vaccine launch

September 5, 2023

Via: PMLiVE

FEATUREDThe investment follows the launch of the company’s new respiratory syncytial virus (RSV) vaccine, Arexvy. Designed to increase the efficiency of manufacturing processes and reduce environmental impact, the new unit will handle freeze-dried vaccines, including Arexvy, as well as the […]


Industry, Vaccines

US government awards $1.4bn for development of COVID-19 vaccines and therapeutics

August 24, 2023

Via: Biopharm International

Royalty Pharma, a company specializing in acquiring pharmaceutical royalties, and Ferring Pharmaceuticals, a biopharmaceutical company with a new gene therapy expected to hit the market, announced that Royalty Pharma had acquired a synthetic royalty on US net sales of Ferring’s […]


Industry, Vaccines

Pfizer’s maternal RSV vaccine granted FDA approval to protect infants

August 22, 2023

Via: PMLiVE

The FDA’s decision allows Abrysvo to be given to those who are 32 to 36 weeks into their pregnancy to prevent lower respiratory tract disease (LRTD) and severe LRTD in infants from birth until they are six months old. RSV […]


Industry, Vaccines

FDA Approves RSV Vaccine, Abrysvo, for Pregnant Women to Help Shield Newborns

August 22, 2023

Via: Drugs.com

Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug Administration approval of the shot, called Abrysvo, on Monday The vaccine is designed […]